Search - Archive ouverte HAL Access content directly

Filter your results

18 Results
authFullName_s : Laurence Albiges

Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

Lisa Derosa , Bertrand Routy , Marine Fidelle , V.Alerio Iebba , Laurie Alla et al.
European Urology, 2020, 78, pp.195-206. ⟨10.1016/j.eururo.2020.04.044⟩
Journal articles hal-02569488v1
Image document

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis

Anne-Gaëlle Goubet , Agathe Dubuisson , Arthur Geraud , François-Xavier Danlos , Safae Terrisse et al.
Cell Death and Differentiation, 2021, ⟨10.1038/s41418-021-00817-9⟩
Journal articles hal-03333920v1

Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase II study

Cedric Lebacle , Karim Bensalah , Jean-Christophe Bernhard , Laurence Albiges , Brigitte Laguerre et al.
BJU International, 2019, 123 (5), pp.804-810. ⟨10.1111/bju.14581⟩
Journal articles hal-03885560v1

Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting

Jean-Alexandre Long , Jean-Christophe Bernhard , Pierre Bigot , Cécilia Lanchon , Philippe Paparel et al.
World Journal of Urology, 2017, 35 (4), pp.649 - 656. ⟨10.1007/s00345-016-1913-4⟩
Journal articles hal-01792768v1

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy , Emmanuelle Le Chatelier , Lisa Derosa , Connie Duong , Maryam Tidjani Alou et al.
Science, 2018, 359 (6371), pp.91-97. ⟨10.1126/science.aan3706⟩
Journal articles hal-02126484v1

Intervention combining Nurse Navigators (NNs) and a mobile application vs. standard of care (SOC) in cancer patients (pts) treated with oral anticancer agents (OAA): results of CAPRI, a single-center, randomized phase 3 trial

Olivier Mir , Marie Ferrua , Aude Fourcade , Delphine Mathivon , Adeline Duflot-Boukobza et al.
ASCO 2020 annual meeting, American Society of Clinical Oncology (ASCO), May 2020, Online, France. pp.abstract 2000
Conference papers hal-03054342v1
Image document

Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade

Stéphane Terry , Cécile Dalban , Nathalie Rioux-Leclercq , Julien Adam , Maxime Meylan et al.
Clinical Cancer Research, 2021, 27 (24), pp.6749-60. ⟨10.1158/1078-0432.CCR-21-0972⟩
Journal articles hal-03477307v1

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program

Laurence Albiges , Aude Fléchon , Christine Chevreau , Delphine Topart , Gwenaëlle Gravis et al.
European Journal of Cancer, 2021, 142, pp.102-111. ⟨10.1016/j.ejca.2020.09.030⟩
Journal articles hal-03623382v1

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

Ronan Flippot , Cécile Dalban , Brigitte Laguerre , Delphine Borchiellini , Gwénaelle Gravis et al.
Journal of Clinical Oncology, 2019, 37 (23), pp.2008--2016. ⟨10.1200/JCO.18.02218⟩
Journal articles hal-02931819v1
Image document

Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage

Aurélie Fluckiger , Romain Daillere , Mohamed Sassi , Barbara S Sixt , Peng Liu et al.
Science, 2020, 369 (6506), pp.936-942. ⟨10.1126/science.aax0701⟩
Journal articles inserm-02923397v1

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status

Yosra Messai , Sophie Gad , Muhammad Zaeem Noman , Gwenael Le Teuff , Sophie Couve et al.
European Urology, 2016, 70 (4), pp.623-632. ⟨10.1016/j.eururo.2015.11.029⟩
Journal articles hal-01255838v1

MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array

Laurence Albiges , Justine Guegan , Audrey Le Formal , Virginie Verkarre , Nathalie Rioux-Leclercq et al.
Clinical Cancer Research, 2014, 20 (13), pp.3411--3421. ⟨10.1158/1078-0432.CCR-13-2173⟩
Journal articles hal-01064619v1
Image document

Chemotherapy in hormone-sensitive metastatic prostate cancer: Evidences and uncertainties from the literature

Gwenaëlle Gravis , François Audenet , Jacques Irani , Marc-Olivier Timsit , Philippe Barthélémy et al.
Cancer Treatment Reviews, 2017, 55, pp.211-217. ⟨10.1016/j.ctrv.2016.09.008⟩
Journal articles hal-01632557v1
Image document

Tumeurs testiculaires : les enjeux diagnostiques de l’imagerie

Laurence Rocher , Aïda Ksouri , Florian Maxwell , Bertrand Bresson , Ghina Hindawi et al.
Bulletin du Cancer, 2019, 106, pp.875 - 886. ⟨10.1016/j.bulcan.2019.03.008⟩
Journal articles hal-03487641v1

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group

Emmanuel Meyer , David Pasquier , Guillemette Bernadou , Gilles Calais , Pierre Maroun et al.
European Journal of Cancer, 2018, 98, pp.38-47. ⟨10.1016/j.ejca.2018.04.008⟩
Journal articles hal-02021697v1

Soluble BTN2A1 Is a Potential Prognosis Biomarker in Pre-Treated Advanced Renal Cell Carcinoma

Emilien Billon , Brice Chanez , Philippe Rochigneux , Laurence Albiges , Cécile Vicier et al.
Frontiers in Immunology, 2021, 12, ⟨10.3389/fimmu.2021.670827⟩
Journal articles hal-03623028v1
Image document

Immunodynamics of explanted human tumors for immuno-oncology

Agathe Dubuisson , Jean Eudes Fahrner , Anne Gaëlle Goubet , Safae A. Terrisse , Nicolas Voisin et al.
EMBO Molecular Medicine, 2021, 13 (1), ⟨10.15252/emmm.202012850⟩
Journal articles hal-03127487v1
Image document

Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial

Olivier Mir , Marie Ferrua , Aude Fourcade , Delphine Mathivon , Adeline Duflot-Boukobza et al.
Nature Medicine, 2022, 28 (6), pp.1224-1231. ⟨10.1038/s41591-022-01788-1⟩
Journal articles hal-03773192v1